Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO in pediatric chronic ITP (CTR20190976)
CTR20190976Phase 3Completed
- Sponsor
- Shenyang Sansheng Pharmaceutical Co., Ltd.
- Start
- Aug 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in chronic primary immune thrombocytopenia (ITP), sponsored by Shenyang Sansheng Pharmaceutical Co., Ltd.. Started Aug 2019; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
chronic primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on CTR20190976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190976.